Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Temozolomide × 90 days × Clear all

Phase

Phase 2 32 Phase 1/2 24 Phase 1 22 Phase 3 10 Phase 2/3 4 Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Standard of Care 69 Interviews as Topic 47 Educational Status 46 Practice Guidelines as Topic 43 Methods 42 Early Intervention, Educational 39 Surveys and Questionnaires 36 Blood Specimen Collection 36 Exercise 34 Magnetic Resonance Spectroscopy 32 Specimen Handling 31 Radiosurgery 21 Radiotherapy 19 Palliative Care 16 Drug Therapy 14 Exercise Test 13 Control Groups 13 Patient Navigation 12 Behavior Therapy 12 X-Rays 11 Biopsy 11 Therapeutics 10 Genetic Testing 10 Acupuncture Therapy 10 Saline Solution 9 Restraint, Physical 9 Resistance Training 9 Physical Therapy Modalities 9 Health Promotion 9 Cognitive Behavioral Therapy 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03257618 2026-03-12

TEMOIN

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Completed

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡